Literature DB >> 19751409

The role of sirtuins in the control of metabolic homeostasis.

Jiujiu Yu1, Johan Auwerx.   

Abstract

Recently the function of the sirtuin family, named after their homology to the Saccharomyces cerevisiae gene silent information regulator 2 (Sir2), has received a lot of attention, as their beneficial impact on longevity was linked to their effects on metabolic control. All sirtuins require nicotinamide adenine dinucleotide (NAD(+)) for their deacetylase or ADP-ribosyl transferase activity, linking their function tightly to cellular energy levels. SIRT1, the founding member of the sirtuin family, modulates many aspects of glucose and lipid homeostasis in almost all key metabolic tissues. Other members including SIRT2, SIRT3, and SIRT4 are also implicated in various metabolic processes. Here, we review the recent data related to the role of sirtuins in the control of metabolic homeostasis and possible underlying molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751409      PMCID: PMC3620552          DOI: 10.1111/j.1749-6632.2009.04952.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  71 in total

1.  Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.

Authors:  J Abraham; J Kelly; P Thibault; S Benchimol
Journal:  J Mol Biol       Date:  2000-01-28       Impact factor: 5.469

2.  The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.

Authors:  J Landry; A Sutton; S T Tafrov; R C Heller; J Stebbins; L Pillus; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.

Authors:  J S Smith; C B Brachmann; I Celic; M A Kenna; S Muhammad; V J Starai; J L Avalos; J C Escalante-Semerena; C Grubmeyer; C Wolberger; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 4.  Unexpected evidence for active brown adipose tissue in adult humans.

Authors:  Jan Nedergaard; Tore Bengtsson; Barbara Cannon
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-01       Impact factor: 4.310

Review 5.  Sirtuin functions in health and disease.

Authors:  Hiroyasu Yamamoto; Kristina Schoonjans; Johan Auwerx
Journal:  Mol Endocrinol       Date:  2007-04-24

6.  Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival.

Authors:  Hongying Yang; Tianle Yang; Joseph A Baur; Evelyn Perez; Takashi Matsui; Juan J Carmona; Dudley W Lamming; Nadja C Souza-Pinto; Vilhelm A Bohr; Anthony Rosenzweig; Rafael de Cabo; Anthony A Sauve; David A Sinclair
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

Review 7.  Sirtuins: the 'magnificent seven', function, metabolism and longevity.

Authors:  Nassim Dali-Youcef; Marie Lagouge; Sébastien Froelich; Christian Koehl; Kristina Schoonjans; Johan Auwerx
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

8.  SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B.

Authors:  Cheng Sun; Fang Zhang; Xinjian Ge; Tingting Yan; Xingmiao Chen; Xianglin Shi; Qiwei Zhai
Journal:  Cell Metab       Date:  2007-10       Impact factor: 27.287

9.  Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.

Authors:  Joseph T Rodgers; Pere Puigserver
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

10.  SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.

Authors:  Enxuan Jing; Stephane Gesta; C Ronald Kahn
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

View more
  67 in total

1.  Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.

Authors:  William C Hallows; Wei Yu; John M Denu
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

Review 2.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

Review 3.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

4.  A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).

Authors:  Brett M Hirsch; Yujun Hao; Xiaopeng Li; Chrys Wesdemiotis; Zhenghe Wang; Weiping Zheng
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

5.  SIRT6: a master epigenetic gatekeeper of glucose metabolism.

Authors:  Lei Zhong; Raul Mostoslavsky
Journal:  Transcription       Date:  2010 Jul-Aug

Review 6.  Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation.

Authors:  Jiujiu Yu; Johan Auwerx
Journal:  Pharmacol Res       Date:  2009-12-21       Impact factor: 7.658

7.  SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes.

Authors:  Richard E Gilbert; Kerri Thai; Suzanne L Advani; Carolyn L Cummins; David M Kepecs; Stephanie A Schroer; Minna Woo; Yanling Zhang
Journal:  Diabetologia       Date:  2015-01-07       Impact factor: 10.122

8.  TGF-β1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway.

Authors:  Yoshifusa Abe; Toru Sakairi; Craig Beeson; Jeffrey B Kopp
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-18

Review 9.  Glucose transporters in the 21st Century.

Authors:  Bernard Thorens; Mike Mueckler
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

10.  Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits.

Authors:  Ayellet V Segrè; Leif Groop; Vamsi K Mootha; Mark J Daly; David Altshuler
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.